MIT AI Drug Discovery: BoltzGen zmienia odkrywanie leków na zawsze
MIT’s BoltzGen generative AI designs proteins for cancer and rare diseases. Pichia-CLM cuts manufacturing costs. The future of medicine is here — March 2026.
MIT’s BoltzGen generative AI designs proteins for cancer and rare diseases. Pichia-CLM cuts manufacturing costs. The future of medicine is here — March 2026.
1 trillion parameters, 1M token context window, multimodality & API costs 10–40× lower than GPT-4o. DeepSeek V4 just rewrote the rules of AI in 2026.